Kappa & Lamda Light Chain measurement plays a key role in diagnosis, monitoring, and prognosis for many patients with a monoclonal gammopathy.
Kappa & Lamda Light Chain Ratio needs blood sample to diagnose, and monitor plasma cell disorders (dyscrasias) such as multiple myeloma, primary amyloidosis, and related diseases or to monitor the effectiveness of treatment.
The exact normal ratio of kappa to lambda, according to a novel polyclonal free light chain assay, ranges from 0.26 to 1.65.
